If you agree, please contact your senators immediately and urge them to cosponsor both S. 113, the Prescription Pricing for the People Act and S. 127, the PBM Transparency Act. Both bills are sponsored by Sens. Maria Cantwell (D-Wash.) and Charles Grassley (R-Iowa). These two bills clarify the enforcement authority of the FTC and other state agencies to bring action against PBMs to ban deceptive PBM practices that drive up the cost of prescription drugs and ensure that the FTC completes its investigation into whether and how consolidation in the PBM and health care marketplaces have led to anti-competitive behaviors. We’re making it easy for you. Just click here to show your support for these measures to hold PBMs accountable.
NCPA
